Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells

Japanese Journal of Cancer Research

Volumn 89, Issue 4, 1998, Pages 397-404

  Takaoka, Akinori ^a   Hinoda, Yuji ^a   Sato, Shuji ^a   Itoh, Fumio ^a   Adachi, Masaaki ^a   Hareyama, Masato ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell adhesion; Invasion; KaI1 gene; Metastasis

Indexed keywords

CALCIUM ION; COMPLEMENTARY DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGGREGATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; LUNG; MELANOMA CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER; SUPPRESSOR GENE;

EID: 0031958941     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00577.x     Document Type: Article

References (25)

1. Dong, J. T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T. and Barrett, J. C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 268, 884-886 (1995).
2. Ueda, T., Ichikawa, T., Tamura, J., Mikata, A., Akakura, K., Akimoto, S., Imai, T., Yoshie, O., Shiraishi, T., Yatani, R., Ito, H. and Shimazaki, J. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am. J. Pathol., 149, 1435-1440 (1996).
3. Boucheix, C., Benoit, P., Frachet, P., Billard, M., Worthington, R. E., Gagnon, J. and Uzan, G. Molecular cloning of the CD9 antigen: a new family of cell surface proteins. J. Biol. Chem., 266, 117-122 (1991).
4. Horejsi, V. and Vlcek, C. Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63 (review). FEBS Lett., 288, 1-4 (1991).
5. Gil, L. M., Vita, N., Lebel-Binay, S., Miloux, B., Chalon, P., Kaghad, M., Marchiol-Fournigaul, C., Conjeaud, H., Caput, D., Ferrara, P., Fradelizi, D. and Quillet-Mary, A. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. J. Immunol., 148, 2826-2833 (1992).
6. Wright, M. D. and Tomlinson, M. G. The ins and outs of the transmembrane 4 superfamily. Immunol. Today, 15, 588-594 (1994).
7. Gaugitsch, H. W., Hofer, E., Huber, N. E., Schnabl, E. and Baumruker, T. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur. J. Immunol., 21, 377-383 (1991).
8. Fukudome, K., Furuse, M., Imai, T., Nishimura, M., Takagi, S., Hinuma, Y. and Yoshie, O. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 of C33 antigen in HTLV-1-positive T cells. J. Virol., 66, 1394-1401 (1992).
9. Imai, T., Fukudome, K., Takagi, S., Nagira, M., Furuse, M., Fukuhara, N., Nishimura, M., Hinuma, Y. and Yoshie, O. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J. Immunol., 149, 2879-2886 (1992).
10. Nojima, Y., Hirose, T., Tachibana, K., Tanaka, T., Shi, L., Doshen, J., Freeman, G. J., Schlossman, S. F. and Morimoto, C. The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. Cell. Immunol., 152, 249-260 (1993).
11. Boucheix, C., Benoit, P., Frachet, P., Billard, M., Worthington, R. E., Gagnon, J. and Uzan, G. Molecular cloning of the CD9 antigen: a new family of cell surface proteins. J. Biol. Chem., 266, 117-122 (1991).
12. Oren, R., Takanashi, S., Doss, C., Levy, R. and Levy, S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol., 10, 4007-4015 (1990).
13. Imai, T. and Yoshie, O. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J. Immunol., 151, 6470-6481 (1993).
14. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. and Arnheim, N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230, 1350-1354 (1985).
15. Takaoka, A., Adachi, M., Okuda, H., Sato, S., Yawata, A., Hinoda, Y., Takayama, S., Reed, J. C. and Imai, K. Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene, 14, 2971-2977 (1997).
16. ++-dependent intercellular adhesion molecule. Cell Growth Differ., 1, 527-533 (1990).
17. Albrecht-Buehler, G. The phagokinetic tracks of 3T3 cells. Cell, 11, 359-404 (1977).
18. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski J. M. and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245 (1987).
19. Repesh, L.A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis, 9, 192-196 (1989).
20. Parish, C. R., Jakobsen, K. B. and Coombe, D. R. A basement membrane permeability assay which correlates with the metastatic potential of tumour cells. Int. J. Cancer, 52, 378-383 (1992).
21. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxocity assays. J. Immunol. Methods, 65, 55-63 (1983).
22. Tada, H., Shiho, O., Kuroshima, K., Koyama, M. and Tsukamoto, K. An improved colorimetric assay for interleukin-2. J. Immunol. Methods, 93, 157-165, (1986).
23. Leone, A., Flatow, U., King, C.E., Sandeen, M. A., Margulies, M. K., Liotta, L. A. and Steeg, P. S. Reduced tumor incidence, metastatic potential and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65, 25-35 (1991).
24. Adachi, M., Taki, T., Ieki, Y., Huang, C.L., Higashiyama, M. and Miyake, M. Correlation of KAI1/ CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res., 56, 1751-1755 (1996).
25. Guo, X., Friess, H., Graber, H. U., Kashiwagi, M., Zimmermann, A., Korc, M. and Buhler, M. W. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res., 56, 4876-4880 (1996).